Regulation of Cre Recombinase Activity by the Synthetic Steroid RU 486

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 1996 Apr 15

PMID 8628671

Citations 70

Authors

C Kellendonk

F Tronche

A P Monaghan

P O Angrand

F Stewart

G Schutz

Affiliations

Soon will be listed here.

Abstract

To create a strategy for inducible gene targeting we developed a Cre-lox recombination system which responds to the synthetic steroid RU 486. Several fusions between Cre recombinase and the hormone binding domain (HBD) of a mutated human progesterone receptor, which binds RU 486 but not progesterone, were constructed. When tested in transient expression assays recombination activities of all fusion proteins were responsive to RU 486, but not to the endogenous steroid progesterone. However, the observed induction of recombination activity by the synthetic steroid varied between the different fusion proteins. The fusion with the highest activity in the presence of RU 486 combined with low background activity in the absence of the steroid was tested after stable expression in fibroblast and embryonal stem (ES) cells. We could demonstrate that its recombination activity was highly dependent on RU 486. Since the RU 486 doses required to activate recombination were considerably lower than doses displaying anti-progesterone effects in mice, this system could be used as a valuable tool for inducible gene targeting.

Citing Articles

Astrocyte-Specific Inhibition of the Primary Cilium Suppresses C3 Expression in Reactive Astrocyte.

Muhamad N, Masutani K, Furukawa S, Yuri S, Toriyama M, Matsumoto C Cell Mol Neurobiol. 2024; 44(1):48.

PMID: 38822888 PMC: 11144130. DOI: 10.1007/s10571-024-01482-5.

Reproducible strategy for excisional skin-wound-healing studies in mice.

Yampolsky M, Bachelet I, Fuchs Y Nat Protoc. 2023; 19(1):184-206.

PMID: 38030941 DOI: 10.1038/s41596-023-00899-4.

Defining Gene Function in Spermatogonial Stem Cells Through Conditional Knockout Approaches.

Legrand J, Hobbs R Methods Mol Biol. 2023; 2656:261-307.

PMID: 37249877 DOI: 10.1007/978-1-0716-3139-3_15.

Exploring animal models in oral cancer research and clinical intervention: A critical review.

Khayatan D, Hussain A, Tebyaniyan H Vet Med Sci. 2023; 9(4):1833-1847.

PMID: 37196179 PMC: 10357283. DOI: 10.1002/vms3.1161.

Annotated expression and activity data for murine recombinase alleles and transgenes: the CrePortal resource.

Perry M, Smith C, Onda H, Ringwald M, Murray S, Smith C Mamm Genome. 2021; 33(1):55-65.

PMID: 34482425 PMC: 8913597. DOI: 10.1007/s00335-021-09909-w.

References

Sternberg N, Hamilton D . Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol. 1981; 150(4):467-86. DOI: 10.1016/0022-2836(81)90375-2. View

JENSEN F, Girardi A, Gilden R, KOPROWSKI H . INFECTION OF HUMAN AND SIMIAN TISSUE CULTURES WITH ROUS SARCOMA VIRUS. Proc Natl Acad Sci U S A. 1964; 52:53-9. PMC: 300571. DOI: 10.1073/pnas.52.1.53. View

Wierzbicki A, Kendall M, Abremski K, Hoess R . A mutational analysis of the bacteriophage P1 recombinase Cre. J Mol Biol. 1987; 195(4):785-94. DOI: 10.1016/0022-2836(87)90484-0. View

Evans R . The steroid and thyroid hormone receptor superfamily. Science. 1988; 240(4854):889-95. PMC: 6159881. DOI: 10.1126/science.3283939. View

Sauer B, Henderson N . Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A. 1988; 85(14):5166-70. PMC: 281709. DOI: 10.1073/pnas.85.14.5166. View

Picard D, Salser S, Yamamoto K . A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell. 1988; 54(7):1073-80. DOI: 10.1016/0092-8674(88)90122-5. View

Guiochon-Mantel A, Loosfelt H, Lescop P, Sar S, Atger M, Perrot-Applanat M . Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers. Cell. 1989; 57(7):1147-54. DOI: 10.1016/0092-8674(89)90052-4. View

Eilers M, Picard D, Yamamoto K, Bishop J . Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature. 1989; 340(6228):66-8. DOI: 10.1038/340066a0. View

Horton R, Hunt H, Ho S, Pullen J, Pease L . Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989; 77(1):61-8. DOI: 10.1016/0378-1119(89)90359-4. View

10.

Baulieu E . Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science. 1989; 245(4924):1351-7. DOI: 10.1126/science.2781282. View

11.

Sauer B, Henderson N . Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol. 1990; 2(5):441-9. View

12.

Dale E, Ow D . Gene transfer with subsequent removal of the selection gene from the host genome. Proc Natl Acad Sci U S A. 1991; 88(23):10558-62. PMC: 52968. DOI: 10.1073/pnas.88.23.10558. View

13.

Vegeto E, Allan G, Schrader W, Tsai M, McDonnell D, OMalley B . The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell. 1992; 69(4):703-13. DOI: 10.1016/0092-8674(92)90234-4. View

14.

Lakso M, Sauer B, Mosinger Jr B, Lee E, Manning R, Yu S . Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A. 1992; 89(14):6232-6. PMC: 49474. DOI: 10.1073/pnas.89.14.6232. View

15.

Orban P, Chui D, Marth J . Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A. 1992; 89(15):6861-5. PMC: 49604. DOI: 10.1073/pnas.89.15.6861. View

16.

Gu H, Zou Y, Rajewsky K . Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell. 1993; 73(6):1155-64. DOI: 10.1016/0092-8674(93)90644-6. View

17.

Jackson P, Baltimore D, Picard D . Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants. EMBO J. 1993; 12(7):2809-19. PMC: 413531. DOI: 10.1002/j.1460-2075.1993.tb05942.x. View

18.

Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder J . Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A. 1993; 90(18):8424-8. PMC: 47369. DOI: 10.1073/pnas.90.18.8424. View

19.

Kilby N, Snaith M, Murray J . Site-specific recombinases: tools for genome engineering. Trends Genet. 1993; 9(12):413-21. DOI: 10.1016/0168-9525(93)90104-p. View

20.

Gu H, Marth J, Orban P, Mossmann H, Rajewsky K . Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 1994; 265(5168):103-6. DOI: 10.1126/science.8016642. View